30 Day Trial
ORTHOKNOW logo

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Current & Critical

MNVC to Provide Startup and Investment Forecasts from Industry Veterans and Newcomers

Twenty-two private companies developing new and emerging technologies, including hardware, biologics, software and diagnostics, are expected to provide pitches at MNVC.

Opportunity in Value-Based Care Lies in Impacting Quality

The mid- to long-term future will require increased evidence to support pricing and value by device companies. It can be contended that broader thinking and strategic response around quality might actually create opportunities for sustained and growing market share for OEMs, as well as greater value for customers—hospitals, physicians and patients.

Spine Industry Reaches “Age of Innovation”

The spine market is saturated with players producing commoditized and some novel technologies. Thus, the amount of strategic activity—funding, M&A, product announcements, etc.—is more robust than any other segment in orthopedics. To understand today’s activity and how it is shaping the market, we spoke with Marc Viscogliosi, Principal at Viscogliosi Brothers and former CEO of Paradigm Spine, about his take on the spine market, and how key pressures play a role in innovation.

Capitalize on These Opportunities in the Emerging Outpatient Surgery Market

In this fourth installment of his quarterly column, Patrick Vega of Vizient Advisory Solutions provides a description of ambulatory settings and strategies, and suggests ways that device companies can capitalize on the shift from inpatient surgical settings to hospital outpatient departments, ASCs and outpatient sites of care.

Contributors to this article hypothesize that device companies that better understand the outpatient setting can more effectively adapt their products, services and support to meet customer needs.

Surgeon Insight: The Future of the Anterior Approach in Hip Replacement

DePuy Synthes announced the Anterior Advantage Matta Method in 1Q19. The namesake of the program, Joel Matta, M.D., is a surgeon at The Steadman Clinic, Co-founder and Chairman of the Anterior Hip Foundation and a pioneer of the anterior approach.

He began using the anterior approach in the late ‘90s and has remained dedicated to the technique, noting that it results in tissue preservation and shorter recovery time. More than two decades later, he remains committed to teaching and advancing the anterior approach. 

Page Navigation
First